The Medical City (TMC) said it is embracing artificial intelligence (AI) and integrated it into its imaging services for chest X-rays.
This significantly enhanced the hospital’s diagnostic capabilities, elevating the compliance rate for finalizing chest X-ray results from 98 percent to 99.88 percent, it said.
It said the improved efficiency amid a 40-percent surge in patient volume underscores its scalability and commitment to delivering timely, accurate care, particularly in urgent scenarios within its emergency department.
TMC also introduced a microwave ablation procedure for tumor debulking, a first in the Philippines, and launched radiofrequency ablation for thyroid nodules, offering patients minimally invasive treatment options that minimize recovery time and enhance outcomes.
Its cardiovascular and neurological institutes are also at the forefront of clinical innovation, it said.
TMC reported the successful implementation of minimally invasive techniques like Transcatheter Aortic Valve Implantation (TAVI) and Outpatient Percutaneous Coronary Intervention (PCI) which revolutionized cardiovascular care, offering patients safer alternatives with quicker recovery times and lower complication risks.
TMC performed its 11th TAVI—the first unproctored procedure within the institution since January 2023—and completed 24 outpatient PCIs, with patients discharged on the same day.
Meanwhile, the hospital’s Mechanical Thrombectomy and the Endovascular Thrombectomy (EVT) program set new benchmarks in stroke care.
The Brain Attack Team’s response time, averaging three minutes, surpasses international standards, ensuring rapid intervention that minimizes the long-term impacts of strokes.
The Mechanical Thrombectomy, a minimally invasive procedure designed to remove blood clots and restore blood flow, has become a cornerstone in treating moderate-to-severe strokes, with TMC achieving a remarkable 92.3% success rate in restoring blood flow in patients since the EVT program’s inception in September 2018.
“Through these initiatives, TMC not only underscores its role as a leader in medical innovation but also reaffirms its deep-seated commitment to enhancing patient care and outcomes in the Philippines and beyond,” the company said.